GP1BA p.Ser441fs
c.1322_1344del · rs770089708 · VCV435346
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | escapes | premature termination codon in the last exon (2 of 2) — the truncated protein is likely expressed. PVS1 input, not an applied code |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP -4.6 | GERP -2.2 |
| Overall | ||
| CADD | 22.0 | PHRED · no single calibrated threshold — expert panels disagree |
| Region caveats | ||
| Repeat context | tandem | CCAAGCCCGACCACCCCAGAGCCCACCTCAGAGCCCGCCCCCAGCCCGACCACCCCGGAGCCCACT simple repeat · ambiguous alignment · confidence, not pathogenicity |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 49.5% | 2 |
| South Asiangrpmax | 25.3% | 4 |
| East Asian | 24.9% | 4 |
| Admixed American | 19.4% | 5 |
| Remaining individualsnot grpmax-eligible | 17.2% | 6 |
| African / African-American | 16.7% | 6 |
| Finnishnot grpmax-eligible | 14.2% | 7 |
| European (non-Finnish) | 13.9% | 7 |
| Middle Eastern | 11.2% | 9 |
| Ashkenazi Jewishnot grpmax-eligible | 9.26% | 11 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GP1BA
- Protein
- p.Ser441fs
- Coding
- c.1322_1344del
- MANE Select
- NM_000173
- dbSNP
- rs770089708
- Type
- Deletion
- Location
- chr17:4933926 (GRCh38)
- Gene constraint
- LOEUF 1.289 · pLI 0.10 (gnomAD)
- Structure
- AlphaFold pLDDT 64.65 · 22 PDB
- Residue 441
- the 'disordered' region
Disease context
nonarteritic anterior ischemic optic neuropathy, susceptibility to — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Bernard-Soulier syndrome, type A2, autosomal dominantplatelet-type von Willebrand diseaseBernard-Soulier syndrome
Similar variants
- GP1BA p.Ala318fs Likely pathogenic ★★★ same condition
- GP1BA p.Arg358_Trp359insTer Likely pathogenic ★★★ same condition
- GP1BA p.Asn32fs Likely pathogenic ★★★ same condition
- GP1BA p.Glu489fs Likely pathogenic ★★★ same condition
- GP1BA p.Leu365fs Likely pathogenic ★★★ same condition
- GP1BA p.Leu531fs Likely pathogenic ★★★ same condition
- GP1BA p.Leu8fs Likely pathogenic ★★★ same condition
- GP1BA p.Leu92fs Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gp1ba-p-ser441fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown